Patient Resources - Results for search Anaphylactic Shock | Sartin\'s Discount Drugs Inc. (228) 864-3514

Health News Results - 8

FDA Approves First Nasal Spray to Curb Anaphylaxis, An Alternative to Injections

Folks nervous about administering a rescue shot for anaphylaxis finally have a new alternative in a nasal spray.

The U.S. Food and Drug Administration on Friday announced that it has approved neffy, the first non-injected treatment for life-threatening allergic reactions.

The epinephrine nasal spray is for use by adults and children who weigh more than 66 pounds, the agency said.

Ernie Mundell HealthDay Reporter
|
August 9, 2024
|
Full Page
- Emergencies / First Aid Allergies: Misc. Anaphylactic Shock

FDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions

In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions.

Approval of the Neffy nasal spray was widely anticipated. An FDA advisory panel voted to recommend approval of the drug for children and adults in May. While the FDA is not obligated to follow the advice of...

Denise Mann HealthDay Reporter
|
September 20, 2023
|
Full Page
- Allergies: Misc. Anaphylactic Shock Food &, Drug Administration

The Most Common Symptoms for Seasonal Allergies, Food Allergies & More

Maybe you can't weed your garden without sneezing. Perhaps your eyes start watering when you clean your home. Did your skin begin itching last night during dinner?

You may have an allergy, but you're not alone. More than 50 million adults and children in the United States have a bad reaction to pollen, dust, mold, pet dander and other common allergens, according to the

Meredith Morckel HealthDay Reporter

May 22, 2023

Full Page

Allergies: Nasal Allergies: Misc. Anaphylactic Shock Skin Disorders: Itchiness Allergies: Food

FDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergy Attacks

Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions.

Although most of the Pulmonary-Allergy Drugs Advisory Committee members supported the spray for adults (16:6) and children (17:5), key questions linger about whether more data is needed from its maker, ARS Pharmaceutical...

Cara Murez HealthDay Reporter
|
May 12, 2023
|
Full Page
- Allergies: Misc. Anaphylactic Shock Food &, Drug Administration Allergies: Food

Latex Allergy: What It Is, Causes, Symptoms & Treatments

Having a latex allergy is no fun, but it can be a real challenge for health professionals who have to work with a wide variety of medical equipment that can contain the allergen.

Latex allergy can trigger a range of symptoms, from itchy hives and rashes to life-threatening anaphylaxis. While StatPearls estimates that it

Ann Schreiber HealthDay Reporter

May 9, 2023

Full Page

Allergies: Misc. Anaphylactic Shock Skin Disorders: Misc.

Food Allergies: Testing, Management & Treatment

So, you ate a banana. You've eaten bananas countless times in the past. But this time, your tongue and lips are itching and your lip is a bit puffy.

If this happens to you, you are likely experiencing food allergy symptoms. You may have just joined the ranks of 32 million Americans who deal with food all...

Ann Schreiber HealthDay Reporter

May 8, 2023

Full Page
- Allergies: Food Food &, Nutrition: Misc. Anaphylactic Shock

Poor Labeling Dangerous to People With Sesame Allergy

Sesame isn't declared on more than half of food products that contain it, which could put some people at risk for an allergic reaction, researchers warn.

A serious allergic reaction (anaphylaxis) can be deadly.

By 2023, sesame will have to be listed on labels of food products sold in the ...

|
February 16, 2022
|
Full Page
- Anaphylactic Shock Allergies: Food

Exposing Kids to Safe Levels of Peanut When Young Might Prevent Allergy

Some kids might be able to get over their peanut allergy if they start immunotherapy while they're still toddlers, a major new clinical trial reports.

In the trial, a group of 1- to 3-year-olds with severe peanut allergies were safely fed gradually increasing daily doses...